Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Review of Reduce Data to Determine the Utility of PSADv While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage

NCT01484808 is registered in ClinicalTrials.gov with University Urological Associates Inc. as lead sponsor.

NCT NCT01484808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01484808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Review of Reduce Data to Determine the Utility of PSADv While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage
Lead sponsor
University Urological Associates Inc.
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
May 31, 2012
Enrollment
6,600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer